Serum urate at trial entry and ALS progression in EMPOWER.

about

Urate Levels Predict Survival in ALS: Analysis of the Expanded PRO-ACT Database.Pre-diagnostic plasma urate and the risk of amyotrophic lateral sclerosis.Serum uric acid levels in patients with amyotrophic lateral sclerosis: a meta-analysis.

P2860

Q38600633-4EFED683-C56F-4B8B-9D3B-7500AA70C725 Q47764404-3A47BA80-5854-4196-91D8-BE6C5F749DD8 Q48216054-59B2C170-6531-4C9E-A291-95DE2E49B2AD

P2860

Serum urate at trial entry and ALS progression in EMPOWER.

Item

http://www.wikidata.org/entity/Q40563709

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Serum urate at trial entry and ALS progression in EMPOWER.

@en

type

Item

label

Serum urate at trial entry and ALS progression in EMPOWER.

@en

prefLabel

Serum urate at trial entry and ALS progression in EMPOWER.

@en

P1476

Serum urate at trial entry and ALS progression in EMPOWER.

@en

P2093

Dawei Liu

http://www.w3.org/2001/XMLSchema#string

Donald R Johns

http://www.w3.org/2001/XMLSchema#string

Melanie Leitner

http://www.w3.org/2001/XMLSchema#string

Sabrina Paganoni

http://www.w3.org/2001/XMLSchema#string

ÉIlis J O'Reilly

http://www.w3.org/2001/XMLSchema#string

P2860

Uric acid provides an antioxidant defense in humans against oxidant- and radical-caused aging and cancer: a hypothesis

Clinical perspective on oxidative stress in sporadic amyotrophic lateral sclerosis

The PRO-ACT database: design, initial analyses, and predictive features

Serum urate as a predictor of clinical and radiographic progression in Parkinson disease.

The relationship between uric acid levels and Huntington's disease progression

Causal Assessment of Serum Urate Levels in Cardiometabolic Diseases Through a Mendelian Randomization Study.

Protection by inosine in a cellular model of Parkinson's disease

Urate as a predictor of the rate of clinical decline in Parkinson disease.

Urate and its transgenic depletion modulate neuronal vulnerability in a cellular model of Parkinson's disease.

Mechanisms, models and biomarkers in amyotrophic lateral sclerosis

P304

120-125

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1080/21678421.2016.1214733

http://www.w3.org/2001/XMLSchema#string

P433

1-2

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Michael A Schwarzschild

Alberto Ascherio

Merit E Cudkowicz

P577

2016-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27677562

http://www.w3.org/2001/XMLSchema#string

P921

amyotrophic lateral sclerosis

P932

5531275

http://www.w3.org/2001/XMLSchema#string

Serum urate at trial entry and ALS progression in EMPOWER.

about

P2860

P2860

Serum urate at trial entry and ALS progression in EMPOWER.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932